OSAM
CHRS icon

O'Shaughnessy Asset Management’s Coherus Oncology CHRS Stock Holding History

O'Shaughnessy Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,207
Closed -$52.8K – 2688
2025
Q4 		$52.8K Sell
37,207
-25,949
-41% -$37.8K ﹤0.01% 2236
2025
Q3 		$104K Buy
+63,156
New +$70.2K ﹤0.01% 2083
2021
Q4 		– Sell
-1,354
Closed -$22K – 1460
2021
Q3 		$22K Hold
1,354
– – ﹤0.01% 1915
2021
Q2 		$19K Buy
1,354
+1,127
+496% +$16K ﹤0.01% 1856
2021
Q1 		$3K Hold
227
– – ﹤0.01% 2006
2020
Q4 		$4K Hold
227
– – ﹤0.01% 1709
2020
Q3 		$4K Hold
227
– – ﹤0.01% 1511
2020
Q2 		$4K Buy
+227
New +$3.84K ﹤0.01% 1395
2020
Q1 		– Sell
-227
Closed -$4K – 1375
2019
Q4 		$4K Buy
+227
New +$4.19K ﹤0.01% 1495

Other funds holding CHRS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return